BUFFALO, N.Y. — A small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of ...
A wearable sensor could vastly improve treatment and drug safety for millions of patients who take lithium for bipolar disorder. Lithium is a highly effective treatment for bipolar disorder, but the ...
Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results